Latest article published from in International Journal of Surgery (Impact Factor: 13.4) on interlinkage between COVID-19 infection mediated aryl hydrocarbon activation and cognitive impairment. Congratulations @Kam_Dua@gauravpharma25@UTSARCCIM
https://t.co/2psehNW5OD
Kudos to all author. @Dinesh_Kumar78@Kam_Dua@gauravpharma25
Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Associatio... https://t.co/4XXJcuPlXH
Today I am happy to share our latest study with impact factor 2.8 on TWEAK Pathway and cancer available at link given below https://t.co/fCBnOqzDxX
@dinesh_kumar78@Kam_Dua@gauravpharma25
Excited to share our latest study on COVID-19 infection and SARS Co V-2 treatment option with combination of two drugs metformin and orlistat in obese diabetic patients Impact factor 3.024
https://t.co/GyAe4fPnEW
@dinesh_kumar78@Kam_Dua@gauravpharma25 @
Sharing the moment of fantabulous time spent by me in jaipur with
Dr. B DINESH KUMAR
Sr. DYP. DIRECTOR
NATIONAL INSTITUTE OF NUTRITION (NIN), @Dineshk38263974@gauravpharma25